IP Library Granted Patent US 7,030,131
Granted Patent B2
US 7,030,131 · App. 10/826,836 · Granted Apr 18, 2006

Sulfonamide substituted imidazoquinolines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,030,131
App. No.
10/826,836
Granted
Apr 18, 2006
Kind
B2
Abstract

Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain sulfonamide or sulfonamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Claims (13)

1. A compound of the formula (I):

wherein

bonds represented by the dashed lines are present or absent;

R 1 is —(CH 2 ) 2-4 —NH—SO 2 —R 4 ;

R 2 is hydrogen, —C 1-4 alkyl, or —C 1-4 alkyl-O—C 1-4 alkyl;

R 4 is C 1-4 alkyl;

n is 0 and each R present is independently selected from the group consisting of C 1-10 alkyl, C 1-10 alkoxy, halogen, and trifluoromethyl;

or a pharmaceutically acceptable salt thereof.

2. A compound or salt according to claim 1 , wherein R 1 is —(CH 2 ) 4 —NH—SO 2 —C 1-4 alkyl, and bonds represented by the dashed lines are present.

3. A compound or salt according to claim 2 , wherein R 1 is —(CH 2 ) 4 —NH—SO 2 —CH 3 , and R 2 is —C 1-4 alkyl.

4. A pharmaceutical composition comprising a therapeutically effective amount of a compound or salt of claim 1 and a pharmaceutically acceptable carrier.

5. A pharmaceutical composition comprising a therapeutically effective amount of a compound or salt of claim 2 and a pharmaceutically acceptable carrier.

6. A pharmaceutical composition comprising a therapeutically effective amount of a compound or salt of claim 3 and a pharmaceutically acceptable carrier.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2011
From: COLEY PHARMACEUTICAL GROUP, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 026167/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2007
From: 3M COMPANY, 3M INNOVATIVE PROPERTIES COMPANY
To: COLEY PHARMACEUTICAL GROUP, INC.
Reel/Frame 020010/0313 →